1. Inhibition of oncogenic MAPK signaling in melanoma triggers SOX2-dependent adaptive drug resistance programs. (July 2016) Authors: Flueckiger, S.; Aloia, A.; Frischknecht, L.; Tuozzo, A.; Croci, D.; Shakhova, O.; Britschgi, C.; Levesque, M.P.; Dummer, R.; Krek, W. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗